Clinical Trial Details
| Trial ID: | L0850 |
| Source ID: | NCT00367146 |
| Associated Drug: | Mmf |
| Title: | MMF After Pediatric Liver Transplantation |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Liver Transplantation|Chronic Kidney Disease |
| Interventions: | DRUG: MMF |
| Outcome Measures: | Primary: safety of a triple immunosuppression (MMF/CSA/Steroids)regarding the number of acute rejections, 1, 3, 6, 9, 12, 24 month | Secondary: incidence of chronic kidney disease, 12, 24 month|incidence of infections, 1, 3, 6, 9, 12, 24 month|incidence of ptld (post transplant lymphoproliferative disease), 1, 3, 6, 9, 12, 24 month |
| Sponsor/Collaborators: | Sponsor: Hannover Medical School |
| Gender: | ALL |
| Age: | CHILD |
| Phases: | |
| Enrollment: | 25 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2004-11 |
| Completion Date: | 2008-08 |
| Results First Posted: | |
| Last Update Posted: | 2011-05-20 |
| Locations: | Hannover medical School, Hannover, 30625, Germany |
| URL: | https://clinicaltrials.gov/show/NCT00367146 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|